Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Jun 30, 2026CallValue
$49,910,980
CallShares
626,000
PutValue
$2,152,710
PutShares
27,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in LQDA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,910,980 | 626,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $2,152,710 | 27,000 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $8,174,484 | 216,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $5,661,000 | 150,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $36,352,460 | 1,054,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $6,546,202 | 189,800 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $5,605,935 | 162,538 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,815,720 | 79,847 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $21,875,880 | 962,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $26,799,090 | 1,178,500 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $1,974,910 | 158,500 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $362,586 | 29,100 | Shares | Sole | 2025-08-14 | |
| 2023-12-31 | $14,436 | 1,200 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $510,272 | 93,800 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $302,115 | 55,536 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $639,200 | 117,500 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $487,448 | 111,800 | Put | Sole | 2022-08-15 | |
| 2022-06-30 | $408,968 | 93,800 | Call | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||